BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 20104492)

  • 1. Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management.
    Emamaullee JA; Edgar R; Toso C; Thiesen A; Bain V; Bigam D; Kneteman N; Shapiro AM
    Liver Transpl; 2010 Feb; 16(2):191-7. PubMed ID: 20104492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases.
    Cheng J; Slavin RE; Gallagher JA; Zhu G; Biehl TR; Swanstrom LL; Hansen PD
    J Hepatobiliary Pancreat Surg; 2004; 11(3):164-70. PubMed ID: 15235888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
    Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
    Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
    Sha D; He YJ
    Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient with liver epithelioid hemangioendothelioma treated by transplantation: 3 years' observation.
    Mucha K; Foroncewicz B; Zieniewicz K; Nyckowski P; Krawczyk M; Cyganek A; Paczek L
    Transplant Proc; 2006; 38(1):231-3. PubMed ID: 16504710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry.
    Lerut JP; Orlando G; Adam R; Schiavo M; Klempnauer J; Mirza D; Boleslawski E; Burroughs A; Sellés CF; Jaeck D; Pfitzmann R; Salizzoni M; Söderdahl G; Steininger R; Wettergren A; Mazzaferro V; Le Treut YP; Karam V;
    Ann Surg; 2007 Dec; 246(6):949-57; discussion 957. PubMed ID: 18043096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic epithelioid hemangioendothelioma: biological questions based on pattern of recurrence in an allograft and tumor immunophenotype.
    Demetris AJ; Minervini M; Raikow RB; Lee RG
    Am J Surg Pathol; 1997 Mar; 21(3):263-70. PubMed ID: 9060595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
    Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
    Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
    Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
    Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component.
    Yuksel H; Kose C; Yilmaz O; Ozbilgin K; Degirmenci PB; Pinar E; Kirmaz C
    Clin Exp Allergy; 2007 Aug; 37(8):1183-8. PubMed ID: 17651148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
    Strizzi L; Catalano A; Vianale G; Orecchia S; Casalini A; Tassi G; Puntoni R; Mutti L; Procopio A
    J Pathol; 2001 Apr; 193(4):468-75. PubMed ID: 11276005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitheloid hemangioendothelioma in patient with liver transplantation.
    Kanizaj TF; Cvrlje VC; Mrzljak A; Kardum-Skelin I; Sustercić D; Segro D; Gustin D; Kocman B
    Coll Antropol; 2010 Mar; 34(1):177-80. PubMed ID: 20432748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered pigment epithelium-derived factor and vascular endothelial growth factor levels in lymphangioma pathogenesis and clinical recurrence.
    Sidle DM; Maddalozzo J; Meier JD; Cornwell M; Stellmach V; Crawford SE
    Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):990-5. PubMed ID: 16301371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.